 | • レポートコード：MRC2-11QY03870 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多重診断のグローバル市場について調査・分析したレポートです。種類別（超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500以上プレックス10,000以下）、中密度マルチプレックスアッセイ（プレックス500以下）、低密度マルチプレックスアッセイ（プレックス5未満）、次世代シーケンシングアッセイ）市場規模、用途別（学術研究所、病院、製薬会社、臨床研究機関、診断研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多重診断の競争状況、市場シェア ・世界の多重診断市場：種類別市場規模 2015年-2020年（超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500以上プレックス10,000以下）、中密度マルチプレックスアッセイ（プレックス500以下）、低密度マルチプレックスアッセイ（プレックス5未満）、次世代シーケンシングアッセイ） ・世界の多重診断市場：種類別市場規模予測 2021年-2026年（超高密度マルチプレックスアッセイ（10,000プレックス以上）、高密度マルチプレックスアッセイ（500以上プレックス10,000以下）、中密度マルチプレックスアッセイ（プレックス500以下）、低密度マルチプレックスアッセイ（プレックス5未満）、次世代シーケンシングアッセイ） ・世界の多重診断市場：用途別市場規模 2015年-2020年（学術研究所、病院、製薬会社、臨床研究機関、診断研究所） ・世界の多重診断市場：用途別市場規模予測 2021年-2026年（学術研究所、病院、製薬会社、臨床研究機関、診断研究所） ・北米の多重診断市場分析：米国、カナダ ・ヨーロッパの多重診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多重診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多重診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多重診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Agilent Technologies、Bio-Rad Laboratories, Inc.、BioMerieux SA、F. Hoffmann-La Roche Ltd.、Illumina, Inc.、Luminex Corporation、Hologic, Inc.、Thermo Fisher Scientific, Inc.、Siemens Healthineers、Abbott Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The key to multiplexing is miniaturization. Instead of having just one assay in a well a whole array of miniaturized, spotted assays is analyzed simultaneously. Combining several tests brings significant savings in time and money.
The growth of private and public funding in the fields of genomics and personalized medicineis currently a high value driver for the global multiplexed diagnostics market. It is boosting the demand for advanced diagnostic technologies for precision-based diagnostics of life-threatening diseases. Current positive trends in the global multiplexed diagnostics market include the increasing rate of extensive research and development efforts being made to expand and diversify the existing applications in multiplexed diagnostics, the development in generic platforms, and a greater use of multiplexed diagnostics in academic and research organizations.
Market Analysis and Insights: Global Multiplexed Diagnostics Market
The global Multiplexed Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Multiplexed Diagnostics Scope and Market Size
Multiplexed Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiplexed Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Agilent Technologies
Bio-Rad Laboratories, Inc.
BioMerieux SA
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Luminex Corporation
Hologic, Inc.
Thermo Fisher Scientific, Inc.
Siemens Healthineers
Abbott Laboratories
Market segment by Type, the product can be split into
Very High Density Multiplexed Assays (Above 10,000-plex)
High Density Multiplexed Assays (500 Below plex Below 10,000)
Medium Density Multiplexed Assays (plex Below 500)
Low Density Multiplexed Assays (plex Below 5)
Next Generation Sequencing Assays
Market segment by Application, split into
Academic Research Institutes
Hospital
Pharmaceutical Companies
Clinical Research Organizations
Diagnostic Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiplexed Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Multiplexed Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Very High Density Multiplexed Assays (Above 10,000-plex)
1.4.3 High Density Multiplexed Assays (500 Below plex Below 10,000)
1.4.4 Medium Density Multiplexed Assays (plex Below 500)
1.4.5 Low Density Multiplexed Assays (plex Below 5)
1.4.6 Next Generation Sequencing Assays
1.5 Market by Application
1.5.1 Global Multiplexed Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Academic Research Institutes
1.5.3 Hospital
1.5.4 Pharmaceutical Companies
1.5.5 Clinical Research Organizations
1.5.6 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Multiplexed Diagnostics Market Perspective (2015-2026)
2.2 Global Multiplexed Diagnostics Growth Trends by Regions
2.2.1 Multiplexed Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Multiplexed Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Multiplexed Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Multiplexed Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Multiplexed Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Multiplexed Diagnostics Players by Market Size
3.1.1 Global Top Multiplexed Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Multiplexed Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Multiplexed Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiplexed Diagnostics Market Concentration Ratio
3.2.1 Global Multiplexed Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Multiplexed Diagnostics Revenue in 2019
3.3 Multiplexed Diagnostics Key Players Head office and Area Served
3.4 Key Players Multiplexed Diagnostics Product Solution and Service
3.5 Date of Enter into Multiplexed Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Multiplexed Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Multiplexed Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Multiplexed Diagnostics Market Size by Application (2015-2020)
5.2 Global Multiplexed Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Multiplexed Diagnostics Market Size (2015-2020)
6.2 Multiplexed Diagnostics Key Players in North America (2019-2020)
6.3 North America Multiplexed Diagnostics Market Size by Type (2015-2020)
6.4 North America Multiplexed Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Multiplexed Diagnostics Market Size (2015-2020)
7.2 Multiplexed Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Multiplexed Diagnostics Market Size by Type (2015-2020)
7.4 Europe Multiplexed Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Multiplexed Diagnostics Market Size (2015-2020)
8.2 Multiplexed Diagnostics Key Players in China (2019-2020)
8.3 China Multiplexed Diagnostics Market Size by Type (2015-2020)
8.4 China Multiplexed Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Multiplexed Diagnostics Market Size (2015-2020)
9.2 Multiplexed Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Multiplexed Diagnostics Market Size by Type (2015-2020)
9.4 Japan Multiplexed Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Multiplexed Diagnostics Market Size (2015-2020)
10.2 Multiplexed Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiplexed Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Multiplexed Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Multiplexed Diagnostics Market Size (2015-2020)
11.2 Multiplexed Diagnostics Key Players in India (2019-2020)
11.3 India Multiplexed Diagnostics Market Size by Type (2015-2020)
11.4 India Multiplexed Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Multiplexed Diagnostics Market Size (2015-2020)
12.2 Multiplexed Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiplexed Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Multiplexed Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies
13.1.1 Agilent Technologies Company Details
13.1.2 Agilent Technologies Business Overview
13.1.3 Agilent Technologies Multiplexed Diagnostics Introduction
13.1.4 Agilent Technologies Revenue in Multiplexed Diagnostics Business (2015-2020))
13.1.5 Agilent Technologies Recent Development
13.2 Bio-Rad Laboratories, Inc.
13.2.1 Bio-Rad Laboratories, Inc. Company Details
13.2.2 Bio-Rad Laboratories, Inc. Business Overview
13.2.3 Bio-Rad Laboratories, Inc. Multiplexed Diagnostics Introduction
13.2.4 Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.2.5 Bio-Rad Laboratories, Inc. Recent Development
13.3 BioMerieux SA
13.3.1 BioMerieux SA Company Details
13.3.2 BioMerieux SA Business Overview
13.3.3 BioMerieux SA Multiplexed Diagnostics Introduction
13.3.4 BioMerieux SA Revenue in Multiplexed Diagnostics Business (2015-2020)
13.3.5 BioMerieux SA Recent Development
13.4 F. Hoffmann-La Roche Ltd.
13.4.1 F. Hoffmann-La Roche Ltd. Company Details
13.4.2 F. Hoffmann-La Roche Ltd. Business Overview
13.4.3 F. Hoffmann-La Roche Ltd. Multiplexed Diagnostics Introduction
13.4.4 F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.4.5 F. Hoffmann-La Roche Ltd. Recent Development
13.5 Illumina, Inc.
13.5.1 Illumina, Inc. Company Details
13.5.2 Illumina, Inc. Business Overview
13.5.3 Illumina, Inc. Multiplexed Diagnostics Introduction
13.5.4 Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.5.5 Illumina, Inc. Recent Development
13.6 Luminex Corporation
13.6.1 Luminex Corporation Company Details
13.6.2 Luminex Corporation Business Overview
13.6.3 Luminex Corporation Multiplexed Diagnostics Introduction
13.6.4 Luminex Corporation Revenue in Multiplexed Diagnostics Business (2015-2020)
13.6.5 Luminex Corporation Recent Development
13.7 Hologic, Inc.
13.7.1 Hologic, Inc. Company Details
13.7.2 Hologic, Inc. Business Overview
13.7.3 Hologic, Inc. Multiplexed Diagnostics Introduction
13.7.4 Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.7.5 Hologic, Inc. Recent Development
13.8 Thermo Fisher Scientific, Inc.
13.8.1 Thermo Fisher Scientific, Inc. Company Details
13.8.2 Thermo Fisher Scientific, Inc. Business Overview
13.8.3 Thermo Fisher Scientific, Inc. Multiplexed Diagnostics Introduction
13.8.4 Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020)
13.8.5 Thermo Fisher Scientific, Inc. Recent Development
13.9 Siemens Healthineers
13.9.1 Siemens Healthineers Company Details
13.9.2 Siemens Healthineers Business Overview
13.9.3 Siemens Healthineers Multiplexed Diagnostics Introduction
13.9.4 Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2015-2020)
13.9.5 Siemens Healthineers Recent Development
13.10 Abbott Laboratories
13.10.1 Abbott Laboratories Company Details
13.10.2 Abbott Laboratories Business Overview
13.10.3 Abbott Laboratories Multiplexed Diagnostics Introduction
13.10.4 Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2015-2020)
13.10.5 Abbott Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Multiplexed Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Multiplexed Diagnostics Revenue
Table 3. Ranking of Global Top Multiplexed Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Multiplexed Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Very High Density Multiplexed Assays (Above 10,000-plex)
Table 6. Key Players of High Density Multiplexed Assays (500 Below plex Below 10,000)
Table 7. Key Players of Medium Density Multiplexed Assays (plex Below 500)
Table 8. Key Players of Low Density Multiplexed Assays (plex Below 5)
Table 9. Key Players of Next Generation Sequencing Assays
Table 10. Global Multiplexed Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Multiplexed Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Multiplexed Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Multiplexed Diagnostics Market Share by Regions (2015-2020)
Table 14. Global Multiplexed Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Multiplexed Diagnostics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Multiplexed Diagnostics Market Growth Strategy
Table 20. Main Points Interviewed from Key Multiplexed Diagnostics Players
Table 21. Global Multiplexed Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Multiplexed Diagnostics Market Share by Players (2015-2020)
Table 23. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiplexed Diagnostics as of 2019)
Table 24. Global Multiplexed Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Multiplexed Diagnostics Product Solution and Service
Table 27. Date of Enter into Multiplexed Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Multiplexed Diagnostics Market Size Share by Type (2015-2020)
Table 31. Global Multiplexed Diagnostics Revenue Market Share by Type (2021-2026)
Table 32. Global Multiplexed Diagnostics Market Size Share by Application (2015-2020)
Table 33. Global Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Multiplexed Diagnostics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 37. North America Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 39. North America Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 41. Europe Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 43. Europe Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 45. Europe Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 47. China Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 49. China Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 50. China Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 51. China Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 52. China Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 53. Japan Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 55. Japan Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 57. Japan Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 61. Southeast Asia Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 63. Southeast Asia Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 65. India Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 67. India Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 68. India Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 69. India Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 70. India Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Multiplexed Diagnostics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Multiplexed Diagnostics Market Share (2019-2020)
Table 73. Central & South America Multiplexed Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Multiplexed Diagnostics Market Share by Type (2015-2020)
Table 75. Central & South America Multiplexed Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Multiplexed Diagnostics Market Share by Application (2015-2020)
Table 77. Agilent Technologies Company Details
Table 78. Agilent Technologies Business Overview
Table 79. Agilent Technologies Product
Table 80. Agilent Technologies Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 81. Agilent Technologies Recent Development
Table 82. Bio-Rad Laboratories, Inc. Company Details
Table 83. Bio-Rad Laboratories, Inc. Business Overview
Table 84. Bio-Rad Laboratories, Inc. Product
Table 85. Bio-Rad Laboratories, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 86. Bio-Rad Laboratories, Inc. Recent Development
Table 87. BioMerieux SA Company Details
Table 88. BioMerieux SA Business Overview
Table 89. BioMerieux SA Product
Table 90. BioMerieux SA Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 91. BioMerieux SA Recent Development
Table 92. F. Hoffmann-La Roche Ltd. Company Details
Table 93. F. Hoffmann-La Roche Ltd. Business Overview
Table 94. F. Hoffmann-La Roche Ltd. Product
Table 95. F. Hoffmann-La Roche Ltd. Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 96. F. Hoffmann-La Roche Ltd. Recent Development
Table 97. Illumina, Inc. Company Details
Table 98. Illumina, Inc. Business Overview
Table 99. Illumina, Inc. Product
Table 100. Illumina, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 101. Illumina, Inc. Recent Development
Table 102. Luminex Corporation Company Details
Table 103. Luminex Corporation Business Overview
Table 104. Luminex Corporation Product
Table 105. Luminex Corporation Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 106. Luminex Corporation Recent Development
Table 107. Hologic, Inc. Company Details
Table 108. Hologic, Inc. Business Overview
Table 109. Hologic, Inc. Product
Table 110. Hologic, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 111. Hologic, Inc. Recent Development
Table 112. Thermo Fisher Scientific, Inc. Business Overview
Table 113. Thermo Fisher Scientific, Inc. Product
Table 114. Thermo Fisher Scientific, Inc. Company Details
Table 115. Thermo Fisher Scientific, Inc. Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 116. Thermo Fisher Scientific, Inc. Recent Development
Table 117. Siemens Healthineers Company Details
Table 118. Siemens Healthineers Business Overview
Table 119. Siemens Healthineers Product
Table 120. Siemens Healthineers Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 121. Siemens Healthineers Recent Development
Table 122. Abbott Laboratories Company Details
Table 123. Abbott Laboratories Business Overview
Table 124. Abbott Laboratories Product
Table 125. Abbott Laboratories Revenue in Multiplexed Diagnostics Business (2015-2020) (Million US$)
Table 126. Abbott Laboratories Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiplexed Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Very High Density Multiplexed Assays (Above 10,000-plex) Features
Figure 3. High Density Multiplexed Assays (500 Below plex Below 10,000) Features
Figure 4. Medium Density Multiplexed Assays (plex Below 500) Features
Figure 5. Low Density Multiplexed Assays (plex Below 5) Features
Figure 6. Next Generation Sequencing Assays Features
Figure 7. Global Multiplexed Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Academic Research Institutes Case Studies
Figure 9. Hospital Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Clinical Research Organizations Case Studies
Figure 12. Diagnostic Laboratories Case Studies
Figure 13. Multiplexed Diagnostics Report Years Considered
Figure 14. Global Multiplexed Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Multiplexed Diagnostics Market Share by Regions: 2020 VS 2026
Figure 16. Global Multiplexed Diagnostics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Multiplexed Diagnostics Market Share by Players in 2019
Figure 19. Global Top Multiplexed Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiplexed Diagnostics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Multiplexed Diagnostics Revenue in 2019
Figure 21. North America Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Multiplexed Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
細胞生存アッセイの世界市場（～2026年） Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment …- 神経科学抗体・アッセイの世界市場（～2026年） The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. Market Analysis and Insights: Global Neuroscience Antibodies and Assa…
- タンパク質アッセイの世界市場（～2026年） Market Analysis and Insights: Global Protein Assays Market The global Protein Assays market size is projected to reach US$ 1468.2 million by 2026, from US$ 1374.6 million in 2020, at a CAGR of 6.3%% during 2021-2026. Global Protein Assays Scope and Market Size Protein Assays market is segmented by T…
- 抗酸化能力アッセイの世界市場（～2026年） Market Analysis and Insights: Global Antioxidant Capacity Assays Market The global Antioxidant Capacity Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Antioxidant Capacity Assays Scope and Market Size Antioxida…
- セルベースアッセイの世界市場（～2026年） Market Analysis and Insights: Global Cell Based Assays Market The global Cell Based Assays market size is projected to reach US$ 13050 million by 2026, from US$ 12390 million in 2020, at a CAGR of 4.9%% during 2021-2026. Global Cell Based Assays Scope and Market Size Cell Based Assays market is segm…